Discontinued — last reported Q4 '25
Product And Service Other — Total revenues
Products & Services · Total revenuesAmgen Product And Service Other — Total revenues remained flat by 0.0% to $400.75M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 14.7%, from $349.50M to $400.75M. Over 3 years (FY 2021 to FY 2025), Product And Service Other — Total revenues shows relatively stable performance with a -1.6% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
How to read this metric
An increase suggests successful monetization of secondary assets or growth in contract services, while a decrease may indicate a decline in royalty income or a strategic shift away from non-core operations.
Detailed definition
This metric represents the aggregate revenue generated from non-core or ancillary business activities that fall outside...
Peer comparison
Peers in the biotechnology and pharmaceutical sectors often report similar 'other' or 'miscellaneous' revenue categories, though the composition varies significantly based on the extent of contract manufacturing and licensing activities.
amgn_segment_other_revenues_total_revenuesHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $412.00M | $386.00M | $575.00M | $507.00M | $313.00M | $320.00M | $320.00M | $320.00M | $320.00M | $349.50M | $349.50M | $349.50M | $349.50M | $400.75M | $400.75M | $400.75M | $400.75M |
| QoQ Change | — | -6.3% | +49.0% | -11.8% | -38.3% | +2.2% | +0.0% | +0.0% | +0.0% | +9.2% | +0.0% | +0.0% | +0.0% | +14.7% | +0.0% | +0.0% | +0.0% |
| YoY Change | — | — | — | — | -24.0% | -36.9% | +2.2% | — | — | +9.2% | +9.2% | +9.2% | +9.2% | +14.7% | +14.7% | +14.7% | +14.7% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Amgen's product and service other — total revenues?
- Amgen (AMGN) reported product and service other — total revenues of $400.75M in Q4 2025.
- How has Amgen's product and service other — total revenues changed year-over-year?
- Amgen's product and service other — total revenues increased by 14.7% year-over-year, from $349.50M to $400.75M.
- What is the long-term trend for Amgen's product and service other — total revenues?
- Over 3 years (2021 to 2025), Amgen's product and service other — total revenues has grown at a -1.6% compound annual growth rate (CAGR), from $1.68B to $1.60B.
- What does product and service other — total revenues mean?
- Total revenue generated from secondary business activities outside of the company's main therapeutic product lines.